» Articles » PMID: 37193312

Multiple Center Research on Relationship Between Screening Quality and Detection of Cervical Cancer - Six Provinces, China, June-December 2021

Overview
Journal China CDC Wkly
Date 2023 May 16
PMID 37193312
Authors
Affiliations
Soon will be listed here.
Abstract

What Is Already Known About This Topic?: The effective implementation of cervical cancer examination programs requires improved cervical cancer screening coverage and quality.

What Is Added By This Report?: The detection rate of ≥high-grade squamous intraepithelial lesions (HSIL) in 6 hospitals was 19.6%. Not having undergone screening in the last 5 years and abnormal screening results had a negative association with detection of ≥HSIL, and abnormal screening results would increase the risk of detection by 75% compared with normal screening results. Additionally, low-grade, high-grade, and cancer of colposcopic impression were associated with a higher risk for detecting ≥HSIL.

What Are The Implications For Public Health Practice?: It is essential to disseminate health knowledge about cervical cancer control to women in order to increase their awareness and screening rates. Additionally, it is necessary to further strengthen the training of professional staff to improve the quality of cervical cancer prevention, including screening, colposcopic examination, and follow-up for target female populations.

Citing Articles

Assessment of Knowledge Gaps in Cervical Cancer Screening and HPV Vaccination Among Chinese Women: A Comprehensive Population-Based Study.

Huang X, Ruan G, Sun P Cancer Manag Res. 2025; 17:267-279.

PMID: 39957903 PMC: 11829636. DOI: 10.2147/CMAR.S500946.


Cancer screening in China: a steep road from evidence to implementation.

Xia C, Basu P, Kramer B, Li H, Qu C, Yu X Lancet Public Health. 2023; 8(12):e996-e1005.

PMID: 38000379 PMC: 10665203. DOI: 10.1016/S2468-2667(23)00186-X.

References
1.
Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P . The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 2021; 385(20):1908-1918. DOI: 10.1056/NEJMsr2030640. View

2.
Benard V, Jackson J, Greek A, Senkomago V, Huh W, Thomas C . A population study of screening history and diagnostic outcomes of women with invasive cervical cancer. Cancer Med. 2021; 10(12):4127-4137. PMC: 8209614. DOI: 10.1002/cam4.3951. View

3.
Zhang M, Zhong Y, Wang L, Bao H, Huang Z, Zhao Z . Cervical Cancer Screening Coverage - China, 2018-2019. China CDC Wkly. 2023; 4(48):1077-1082. PMC: 9889230. DOI: 10.46234/ccdcw2022.217. View

4.
Bedell S, Goldstein L, Goldstein A, Goldstein A . Cervical Cancer Screening: Past, Present, and Future. Sex Med Rev. 2019; 8(1):28-37. DOI: 10.1016/j.sxmr.2019.09.005. View

5.
Bchtawi A, Saritas S, Schledermann D, Christensen R, Jochumsen K . Screening history and FIGO-stages among Danish women with cervical cancer in 2012-2014: a register-based study. Sci Rep. 2020; 9(1):20390. PMC: 6938494. DOI: 10.1038/s41598-019-56833-w. View